MedPath

A clinical trial to study the efficacy of different volumes of 0.2% ropivacaine in suprainguinal fascia iliaca compartment block for multimodal analgesia in lower limb surgery

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/09/036144
Lead Sponsor
Dayanand Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients scheduled for lower limb surgeries, including the hip and uptown the knee joint

-ASA I,II and III patients

-Cognitive ability to comprehend NRS scale

Exclusion Criteria

-Patient refusal

-Contraindications to the suprainguinal fascia iliaca compartment block (such as coagulopathies, infection at injection site, allergy to local anaesthetic)

-Patient on chronic opiod abuse

-Neuropathies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To comparatively evaluate the efficacy of different volumes of ropivacaine in suprainguinal fascia iliaca compartment block for multimodal analgesia in lower limb surgeries <br/ ><br>-Time to first request of rescue analgesia with in first 24 hours after surgery <br/ ><br>-Total requirement of analgesics for pain management in first 24 hoursTimepoint: To comparatively evaluate the efficacy of different volumes of ropivacaine in suprainguinal fascia iliaca compartment block for multimodal analgesia in lower limb surgeries <br/ ><br>-Time to first request of rescue analgesia with in first 24 hours after surgery <br/ ><br>-Total requirement of analgesics for pain management in first 24 hours
Secondary Outcome Measures
NameTimeMethod
Patient satisfaction with pain managementTimepoint: 24 hours
© Copyright 2025. All Rights Reserved by MedPath